198 related articles for article (PubMed ID: 1980007)
21. Aberrant imprinting of the insulin-like growth factor II receptor gene in Wilms' tumor.
Xu YQ; Grundy P; Polychronakos C
Oncogene; 1997 Mar; 14(9):1041-6. PubMed ID: 9070652
[TBL] [Abstract][Full Text] [Related]
22. Identification of novel regions of deletion in familial Wilms' tumor by comparative genomic hybridization.
Altura RA; Valentine M; Li H; Boyett JM; Shearer P; Grundy P; Shapiro DN; Look AT
Cancer Res; 1996 Aug; 56(16):3837-41. PubMed ID: 8706032
[TBL] [Abstract][Full Text] [Related]
23. Molecular genetic evidence for common pathogenesis of childhood and adult Wilms' tumor.
Kozman HM; Clarke JM; Little MH; Smith PJ
Cancer Genet Cytogenet; 1989 Mar; 38(1):121-5. PubMed ID: 2540899
[TBL] [Abstract][Full Text] [Related]
24. Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome.
Grundy PE; Telzerow PE; Breslow N; Moksness J; Huff V; Paterson MC
Cancer Res; 1994 May; 54(9):2331-3. PubMed ID: 8162576
[TBL] [Abstract][Full Text] [Related]
25. Homozygous intragenic deletion in the WT1 gene in a sporadic Wilms' tumour associated with high levels of expression of a truncated transcript.
Algar EM; Kenney MT; Simms LA; Smith SI; Kida Y; Smith PJ
Hum Mutat; 1995; 5(3):221-7. PubMed ID: 7599632
[TBL] [Abstract][Full Text] [Related]
26. Structural rearrangements of the WT1 gene in Wilms' tumour cells.
Cowell JK; Wadey RB; Haber DA; Call KM; Housman DE; Pritchard J
Oncogene; 1991 Apr; 6(4):595-9. PubMed ID: 1851548
[TBL] [Abstract][Full Text] [Related]
27. Loss of chromosome 11p alleles in cultured cells derived from Wilms' tumours.
Brown KW; Shaw AP; Poirier V; Tyler SJ; Berry PJ; Mott MG; Maitland NJ
Br J Cancer; 1989 Jul; 60(1):25-9. PubMed ID: 2553087
[TBL] [Abstract][Full Text] [Related]
28. Loss of heterozygosity for chromosome region 11p15 in Wilms' tumours is not related to HRAS gene transforming mutations.
Baird P; Wadey R; Cowell J
Oncogene; 1991 Jul; 6(7):1147-9. PubMed ID: 1861864
[TBL] [Abstract][Full Text] [Related]
29. [Molecular genetics of Wilms' tumor].
Papezová M; Mares J; Goetz P
Cas Lek Cesk; 2001 Jun; 140(11):323-7. PubMed ID: 11431850
[TBL] [Abstract][Full Text] [Related]
30. Infrequent mutation of the WT1 gene in 77 Wilms' Tumors.
Gessler M; König A; Arden K; Grundy P; Orkin S; Sallan S; Peters C; Ruyle S; Mandell J; Li F
Hum Mutat; 1994; 3(3):212-22. PubMed ID: 8019557
[TBL] [Abstract][Full Text] [Related]
31. Loss of genes on the long arm of chromosome 22 in human meningiomas.
Okazaki M; Nishisho I; Tateishi H; Motomura K; Yamamoto M; Miki T; Hayakawa T; Takai S; Honjo T; Mori T
Mol Biol Med; 1988 Feb; 5(1):15-22. PubMed ID: 2897611
[TBL] [Abstract][Full Text] [Related]
32. Paternally inherited submicroscopic duplication at 11p15.5 implicates insulin-like growth factor II in overgrowth and Wilms' tumorigenesis.
Algar EM; St Heaps L; Darmanian A; Dagar V; Prawitt D; Peters GB; Collins F
Cancer Res; 2007 Mar; 67(5):2360-5. PubMed ID: 17325026
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of the insulin-like growth factor-II gene in Wilms' tumor is not dependent on loss of genomic imprinting or loss of heterozygosity.
Wang WH; Duan JX; Vu TH; Hoffman AR
J Biol Chem; 1996 Nov; 271(44):27863-70. PubMed ID: 8910385
[TBL] [Abstract][Full Text] [Related]
34. Maintenance of genomic imprinting at the IGF2 locus in hepatoblastoma.
Davies SM
Cancer Res; 1993 Oct; 53(20):4781-3. PubMed ID: 8402661
[TBL] [Abstract][Full Text] [Related]
35. Loss of heterozygosity at 11p13 in Wilms' tumours does not necessarily involve mutations in the WT1 gene.
Cowell JK; Groves N; Baird P
Br J Cancer; 1993 Jun; 67(6):1259-61. PubMed ID: 8390282
[TBL] [Abstract][Full Text] [Related]
36. Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification.
Caron H; van Sluis P; van Hoeve M; de Kraker J; Bras J; Slater R; Mannens M; Voûte PA; Westerveld A; Versteeg R
Nat Genet; 1993 Jun; 4(2):187-90. PubMed ID: 8102298
[TBL] [Abstract][Full Text] [Related]
37. Preferential germline mutation of the paternal allele in retinoblastoma.
Zhu XP; Dunn JM; Phillips RA; Goddard AD; Paton KE; Becker A; Gallie BL
Nature; 1989 Jul; 340(6231):312-3. PubMed ID: 2568588
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathologic correlates of loss of heterozygosity in Wilm's tumor: a preliminary analysis.
Grundy P; Telzerow P; Moksness J; Breslow NE
Med Pediatr Oncol; 1996 Nov; 27(5):429-33. PubMed ID: 8926924
[TBL] [Abstract][Full Text] [Related]
39. Wilms' tumour and related syndromes. A unifying theory.
Côté GB
Ann Genet; 1989; 32(2):69-72. PubMed ID: 2547332
[TBL] [Abstract][Full Text] [Related]
40. Allelotyping in Wilms tumors identifies a putative third tumor suppressor gene on chromosome 11.
Radice P; Perotti D; De Benedetti V; Mondini P; Radice MT; Pilotti S; Luksch R; Fossati Bellani F; Pierotti MA
Genomics; 1995 Jun; 27(3):497-501. PubMed ID: 7558032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
